Chloe Botaine

Today we're joined by Ivan Kairatov, a biopharma expert at the forefront of integrating artificial intelligence into oncology. His team’s latest work, leveraging data from the landmark TAILORx trial, has produced an AI model that significantly refines our ability to predict long-term recurrence

For the millions of individuals navigating the relentless progression of diabetic kidney disease, the best-case scenario offered by modern medicine has long been a managed decline—a slowing of the inevitable slide toward renal failure and the need for life-altering dialysis or transplantation. This

A recent scientific breakthrough has shed light on a promising new strategy against ovarian cancer, demonstrating how a natural compound derived from a traditional herb can selectively destroy malignant cells by disrupting their internal waste management system. The study, a collaborative effort

For individuals with compromised immune systems, such as those recovering from intensive cancer treatments, the common herpes simplex virus can transform from a manageable nuisance into a severe, life-threatening adversary. The clinical challenge intensifies dramatically when the virus evolves

In the intricate world of medical imaging, the human eye, despite its remarkable capabilities and years of training, is not infallible, and a single, overlooked shadow on a brain scan can have profound consequences for a patient's diagnosis and treatment path. The immense pressure on radiologists

The blueprint for medical innovation is being rewritten not in laboratories of glass and steel, but in the digital and genetic code that now defines the vanguard of biotechnology. A fundamental transformation is underway, moving the industry beyond speculative research and into an era of

A new multi-million-dollar investment is poised to reshape the landscape of cancer research by focusing intensely on the unique health challenges faced by the communities of South Texas. The Cancer Prevention Research Institute of Texas (CPRIT) has announced a significant financial commitment of

The invisible wounds of trauma have long presented a formidable challenge for modern medicine, particularly in the diagnosis of Post-Traumatic Stress Disorder, a condition historically reliant on the subjective and often fluctuating self-reports of patients. For the approximately 23% of 9/11 World

The intricate dance between the human immune system and a developing tumor has long been the central stage for oncology's most ambitious therapeutic strategies. In the ongoing quest to empower the body's natural defenses against cancer, researchers have identified key proteins, known as immune

The ubiquitous glow of a computer screen in the modern exam room has become a double-edged sword, streamlining medical data management while simultaneously erecting a digital barrier between clinicians and the very patients they aim to serve. As healthcare systems grapple with this new dynamic, the